Microbot Medical Inc. (NASDAQ:MBOT) Director Yoseph Bornstein sold 50,000 shares of the stock in a transaction dated Tuesday, October 17th. The stock was sold at an average price of $1.16, for a total transaction of $58,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Yoseph Bornstein also recently made the following trade(s):

  • On Tuesday, October 10th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.38, for a total transaction of $69,000.00.
  • On Thursday, October 5th, Yoseph Bornstein sold 22,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.49, for a total transaction of $32,780.00.
  • On Wednesday, October 4th, Yoseph Bornstein sold 53,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.20, for a total transaction of $63,600.00.
  • On Tuesday, September 26th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.24, for a total transaction of $62,000.00.
  • On Tuesday, September 19th, Yoseph Bornstein sold 50,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.18, for a total transaction of $59,000.00.
  • On Tuesday, September 12th, Yoseph Bornstein sold 20,000 shares of Microbot Medical stock. The stock was sold at an average price of $1.12, for a total transaction of $22,400.00.
  • On Wednesday, September 6th, Yoseph Bornstein sold 45,610 shares of Microbot Medical stock. The stock was sold at an average price of $1.01, for a total transaction of $46,066.10.

Shares of Microbot Medical Inc. (NASDAQ:MBOT) traded down 1.351% during trading on Thursday, reaching $1.095. 240,064 shares of the company’s stock were exchanged. Microbot Medical Inc. has a 12-month low of $1.00 and a 12-month high of $15.66. The company has a 50 day moving average of $1.21 and a 200 day moving average of $2.17. The stock’s market cap is $48.22 million.

Microbot Medical (NASDAQ:MBOT) last announced its quarterly earnings results on Monday, August 14th. The biotechnology company reported ($0.04) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.48) by $0.44. Equities research analysts anticipate that Microbot Medical Inc. will post ($25.02) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Microbot Medical Inc. (MBOT) Director Yoseph Bornstein Sells 50,000 Shares of Stock” was published by Watch List News and is the property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and republished in violation of United States & international copyright & trademark legislation. The legal version of this piece can be accessed at https://www.watchlistnews.com/microbot-medical-inc-mbot-director-yoseph-bornstein-sells-50000-shares-of-stock/1656255.html.

A hedge fund recently bought a new stake in Microbot Medical stock. Sabby Management LLC purchased a new stake in Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 1,285,351 shares of the biotechnology company’s stock, valued at approximately $1,825,000. Sabby Management LLC owned 2.92% of Microbot Medical at the end of the most recent reporting period. 4.66% of the stock is currently owned by hedge funds and other institutional investors.

About Microbot Medical

Microbot Medical Inc, formerly StemCells, Inc, is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures.

Insider Buying and Selling by Quarter for Microbot Medical (NASDAQ:MBOT)

Receive News & Ratings for Microbot Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.